Perspective

You have free access to this content

Role of the Osteoblast Lineage in the Bone Marrow Hematopoietic Niches†

  1. Joy Y Wu1,
  2. David T Scadden2,3,
  3. Henry M Kronenberg1,*

Article first published online: 16 FEB 2009

DOI: 10.1359/jbmr.090225

Issue

Journal of Bone and Mineral Research

Journal of Bone and Mineral Research

Volume 24, Issue 5, pages 759–764, May 2009

Additional Information

How to Cite

Wu, J. Y., Scadden, D. T. and Kronenberg, H. M. (2009), Role of the Osteoblast Lineage in the Bone Marrow Hematopoietic Niches. J Bone Miner Res, 24: 759–764. doi: 10.1359/jbmr.090225

Author Information

  1. 1

    Endocrine Unit, Boston, Massachusetts, USA

  2. 2

    Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA

  3. 3

    Harvard Stem Cell Institute, Cambridge, Massachusetts, USA

*Address correspondence to: Henry M. Kronenberg, MD, Endocrine Unit, Massachusetts General Hospital, 50 Blossom Street, Thier 1101, Boston, MA 02114, USA

  1. †

    Dr. Scadden is a consultant and shareholder in Fate Therapeutics, a consultant for Genzyme and a Scientific Advisory Board Member for Hospira. All other authors state that they have no conflicts of interest.

Publication History

  1. Issue published online: 4 DEC 2009
  2. Article first published online: 16 FEB 2009
  3. Manuscript Accepted: 12 FEB 2009
  4. Manuscript Revised: 12 JAN 2009
  5. Manuscript Received: 15 DEC 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (643K)

REFERENCES

  • 1
    Godin I, Cumano A 2002 The hare and the tortoise: An embryonic haematopoietic race. Nat Rev Immunol 2: 593–604.
  • 2
    Schofield R 1978 The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4: 7–25.
  • 3
    Adams GB, Scadden DT 2006 The hematopoietic stem cell in its place. Nat Immunol 7: 333–337.
  • 4
    Wilson A, Trumpp A 2006 Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 6: 93–106.
  • 5
    Kiel MJ, Morrison SJ 2008 Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 8: 290–301.
  • 6
    Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P 2007 Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324–336.
  • 7
    Lo Celso C, Fleming HE, Wu JW, Zhao CX, Miake-Lye S, Fujisaki J, Cote D, Rowe DW, Lin CP, Scadden DT 2009 Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457: 92–96.
  • 8
    Xie Y, Yin T, Wiegraebe W, He XC, Miller D, Stark D, Perko K, Alexander R, Schwartz J, Grindley JC, Park J, Haug JS, Wunderlich JP, Li H, Zhang S, Johnson T, Feldman RA, Li L 2009 Detection of functional haematopoietic stem cell niche using real-time imaging. Nature 457: 97–101.
  • 9
    Aubin JE, Triffit JT 2002 Mesenchymal stem cells and osteoblast differentiation. In: BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology, 2nd ed ., vol. 1. Academic Press, New York, NY, USA, 59–81.
  • 10
    Manolagas SC 2000 Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21: 115–137.
  • 11
    Pyrah LN, Hodgkinson A, Anderson CK 1966 Primary hyperparathyroidism. Br J Surg 53: 245–316.
    Direct Link:
  • 12
    Marie PJ, de Pollak C, Chanson P, Lomri A 1997 Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol 150: 1059–1069.
  • 13
    Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, Kronenberg HM, Baron R, Schipani E 2001 Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 107: 277–286.
  • 14
    Lotinun S, Sibonga JD, Turner RT 2005 Evidence that the cells responsible for marrow fibrosis in a rat model for hyperparathyroidism are preosteoblasts. Endocrinology 146: 4074–4081.
  • 15
    Wang YH, Liu Y, Buhl K, Rowe DW 2005 Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP. J Bone Miner Res 20: 5–14.
    Direct Link:
  • 16
    Bilic-Curcic I, Kronenberg M, Jiang X, Bellizzi J, Mina M, Marijanovic I, Gardiner EM, Rowe DW 2005 Visualizing levels of osteoblast differentiation by a two-color promoter-GFP strategy: Type I collagen-GFPcyan and osteocalcin-GFPtpz. Genesis 43: 87–98.
    Direct Link:
  • 17
    Day TF, Guo X, Garrett-Beal L, Yang Y 2005 Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8: 739–750.
  • 18
    Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C 2005 Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8: 727–738.
  • 19
    Rodda SJ, McMahon AP 2006 Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133: 3231–3244.
  • 20
    Glass DA II , Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G 2005 Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8: 751–764.
  • 21
    Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, Deng L, Clemens TL, Williams BO 2005 Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem 280: 21162–21168.
  • 22
    Lord BI, Testa NG, Hendry JH 1975 The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood 46: 65–72.
  • 23
    Gong JK 1978 Endosteal marrow: A rich source of hematopoietic stem cells. Science 199: 1443–1445.
  • 24
    Lambertsen RH, Weiss L 1984 A model of intramedullary hematopoietic microenvironments based on stereologic study of the distribution of endocloned marrow colonies. Blood 63: 287–297.
  • 25
    Nilsson SK, Johnston HM, Coverdale JA 2001 Spatial localization of transplanted hemopoietic stem cells: Inferences for the localization of stem cell niches. Blood 97: 2293–2299.
  • 26
    Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ 1997 Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765–771.
  • 27
    Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755–764.
  • 28
    Deguchi K, Yagi H, Inada M, Yoshizaki K, Kishimoto T, Komori T 1999 Excessive extramedullary hematopoiesis in Cbfa1-deficient mice with a congenital lack of bone marrow. Biochem Biophys Res Commun 255: 352–359.
  • 29
    Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD 1990 The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442–444.
  • 30
    Sutherland HJ, Lansdorp PM, Henkelman DH, Eaves AC, Eaves CJ 1990 Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 87: 3584–3588.
  • 31
    Taichman RS, Reilly MJ, Emerson SG 1996 Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood 87: 518–524.
  • 32
    Taichman RS, Emerson SG 1998 The role of osteoblasts in the hematopoietic microenvironment. Stem Cells 16: 7–15.
    Direct Link:
  • 33
    Visnjic D, Kalajzic I, Gronowicz G, Aguila HL, Clark SH, Lichtler AC, Rowe DW 2001 Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice. J Bone Miner Res 16: 2222–2231.
    Direct Link:
  • 34
    Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aguila HL 2004 Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103: 3258–3264.
  • 35
    Zhu J, Garrett R, Jung Y, Zhang Y, Kim N, Wang J, Joe GJ, Hexner E, Choi Y, Taichman RS, Emerson SG 2007 Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood 109: 3706–3712.
  • 36
    Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA, Frenette PS 2006 Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124: 407–421.
  • 37
    Mayack SR, Wagers AJ 2008 Osteolineage niche cells initiate hematopoietic stem cell mobilization. Blood 112: 519–531.
  • 38
    Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT 2003 Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841–846.
  • 39
    Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li L 2003 Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425: 836–841.
  • 40
    Kiel MJ, Radice GL, Morrison SJ 2007 Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance. Cell Stem Cell 1: 204–217.
  • 41
    Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh GY, Suda T 2004 Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118: 149–161.
  • 42
    Stier S, Ko Y, Forkert R, Lutz C, Neuhaus T, Grunewald E, Cheng T, Dombkowski D, Calvi LM, Rittling SR, Scadden DT 2005 Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 201: 1781–1791.
  • 43
    Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, Bertoncello I, Bendall LJ, Simmons PJ, Haylock DN 2005 Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106: 1232–1239.
  • 44
    Yoshihara H, Arai F, Hosokawa K, Hagiwara T, Takubo K, Nakamura Y, Gomei Y, Iwasaki H, Matsuoka S, Miyamoto K, Miyazaki H, Takahashi T, Suda T 2007 Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 1: 685–697.
  • 45
    Fleming HE, Janzen V, Lo Celso C, Guo J, Leahy KM, Kronenberg HM, Scadden DT 2008 Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell 2: 274–283.
  • 46
    Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznansky MC, Kos CH, Pollak MR, Brown EM, Scadden DT 2006 Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439: 599–603.
  • 47
    Mancini SJ, Mantei N, Dumortier A, Suter U, MacDonald HR, Radtke F 2005 Jagged1-dependent Notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation. Blood 105: 2340–2342.
  • 48
    Haug JS, He XC, Grindley JC, Wunderlich JP, Gaudenz K, Ross JT, Paulson A, Wagner KP, Xie Y, Zhu R, Yin T, Perry JM, Hembree MJ, Redenbaugh EP, Radice GL, Seidel C, Li L 2008 N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells. Cell Stem Cell 2: 367–379.
  • 49
    Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, Jin DK, Dias S, Zhang F, Hartman TE, Hackett NR, Crystal RG, Witte L, Hicklin DJ, Bohlen P, Eaton D, Lyden D, de Sauvage F, Rafii S 2004 Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 10: 64–71.
  • 50
    Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K 1991 Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 173: 1213–1225.
  • 51
    Tokoyoda K, Egawa T, Sugiyama T, Choi BI, Nagasawa T 2004 Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20: 707–718.
  • 52
    Sapoznikov A, Pewzner-Jung Y, Kalchenko V, Krauthgamer R, Shachar I, Jung S 2008 Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nat Immunol 9: 388–395.
  • 53
    Jung Y, Wang J, Schneider A, Sun YX, Koh-Paige AJ, Osman NI, McCauley LK, Taichman RS 2006 Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. Bone 38: 497–508.
  • 54
    Juppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski LF Jr , Hock J, Potts JT Jr , Kronenberg HM, Segre GV 1991 A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254: 1024–1026.
  • 55
    Wu J, Purton LE, Rodda SJ, Chen M, Weinstein LS, McMahon AP, Scadden DT, Kronenberg HM 2008 Osteoblastic regulation of B lymphopoiesis is mediated by Gsalpha-dependent signaling pathways. Proc Natl Acad Sci USA 105: 16976–16981.
  • 56
    Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, Meyer JD, Davison BL 1994 Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 180: 1955–1960.
  • 57
    von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R 1995 Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 181: 1519–1526.
  • 58
    Suda M, Tanaka K, Natsui K, Usui T, Tanaka I, Fukushima M, Shigeno C, Konishi J, Narumiya S, Ichikawa A, Nakao N 1996 Prostaglandin E receptor subtypes in mouse osteoblastic cell line. Endocrinology 137: 1698–1705.
  • 59
    North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM, Weber GJ, Bowman TV, Jang IH, Grosser T, Fitzgerald GA, Daley GQ, Orkin SH, Zon LI 2007 Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447: 1007–1011.
  • 60
    Nagasawa T 2006 Microenvironmental niches in the bone marrow required for B-cell development. Nat Rev Immunol 6: 107–116.
  • 61
    Wilson A, Laurenti E, Oser G, van der Wath RC, Blanco-Bose W, Jaworski M, Offner S, Dunant CF, Eshkind L, Bockamp E, Lio P, Macdonald HR, Trumpp A 2008 Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135: 1118–1129.
  • 62
    Balduino A, Hurtado SP, Frazao P, Takiya CM, Alves LM, Nasciutti LE, El-Cheikh MC, Borojevic R 2005 Bone marrow subendosteal microenvironment harbours functionally distinct haemosupportive stromal cell populations. Cell Tissue Res 319: 255–266.
  • 63
    Walkley CR, Shea JM, Sims NA, Purton LE, Orkin SH 2007 Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 129: 1081–1095.
  • 64
    Walkley CR, Olsen GH, Dworkin S, Fabb SA, Swann J, McArthur GA, Westmoreland SV, Chambon P, Scadden DT, Purton LE 2007 A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 129: 1097–1110.
  • 65
    Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, Marshall D, Fu L, Januario T, Kallop D, Nannini-Pepe M, Kotkow K, Marsters JC, Rubin LL, de Sauvage FJ 2008 A paracrine requirement for hedgehog signalling in cancer. Nature 455: 406–410.
  • 66
    Yang FC, Ingram DA, Chen S, Zhu Y, Yuan J, Li X, Yang X, Knowles S, Horn W, Li Y, Zhang S, Yang Y, Vakili ST, Yu M, Burns D, Robertson K, Hutchins G, Parada LF, Clapp DW 2008 Nf1-dependent tumors require a microenvironment containing Nf1+/−- and c-kit-dependent bone marrow. Cell 135: 437–448.
  • 67
    Edwards CM, Zhuang J, Mundy GR 2008 The pathogenesis of the bone disease of multiple myeloma. Bone 42: 1007–1013.
  • 68
    Wei J, Wunderlich M, Fox C, Alvarez S, Cigudosa JC, Wilhelm JS, Zheng Y, Cancelas JA, Gu Y, Jansen M, Dimartino JF, Mulloy JC 2008 Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Cancer Cell 13: 483–495.
  • 69
    Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, Nakamura R, Tanaka T, Tomiyama H, Saito N, Fukata M, Miyamoto T, Lyons B, Ohshima K, Uchida N, Taniguchi S, Ohara O, Akashi K, Harada M, Shultz LD 2007 Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol 25: 1315–1321.
  • 70
    Ninomiya M, Abe A, Katsumi A, Xu J, Ito M, Arai F, Suda T, Kiyoi H, Kinoshita T, Naoe T 2007 Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice. Leukemia 21: 136–142.
  • 71
    Jung Y, Song J, Shiozawa Y, Wang J, Wang Z, Williams B, Havens A, Schneider A, Ge C, Franceschi RT, McCauley LK, Krebsbach PH, Taichman RS 2008 Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche. Stem Cells 26: 2042–2051.
    Direct Link:
  • 72
    Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T 1988 Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122: 1373–1382.
  • 73
    Kollet O, Dar A, Shivtiel S, Kalinkovich A, Lapid K, Sztainberg Y, Tesio M, Samstein RM, Goichberg P, Spiegel A, Elson A, Lapidot T 2006 Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 12: 657–664.
  • 74
    Kuhn R, Schwenk F, Aguet M, Rajewsky K 1995 Inducible gene targeting in mice. Science 269: 1427–1429.
  • 75
    Walkley CR, Qudsi R, Sankaran VG, Perry JA, Gostissa M, Roth SI, Rodda SJ, Snay E, Dunning P, Fahey FH, Alt FW, McMahon AP, Orkin SH 2008 Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev 22: 1662–1676.
View Full Article (HTML) Get PDF (643K)